Home
Contact
Sitemap
Search
ABOUT PHOTOCURE
NEWS
News archive
PRODUCTS
OUR TECHNOLOGY
R&D
INVESTORS
BUSINESS DEVELOPMENT
PRESS/MEDIA
NEWS
Subscribe to our news.
News
2010.05.30
Photocure announces US approval of Cysview(TM) for detection of bladder cancer
2010.05.28
Photocure announces results from phase II study in acne with Visonac™
2010.05.26
Feil i regelverket for Innsatsstyrt Finansiering
2010.05.11
Photocure wins patent case against the US Patent and Trademark Office
2010.04.28
1st quarter 2010 results
2010.04.27
Åse Aulie Michelet foreslås som nytt styremedlem i Photocure
2010.04.26
Presentation of the 1st quarter 2010 report
2010.04.21
Expert panel recommends the use of Hexvix®-cystoscopy
2010.04.07
Notice of annual general meeting
2010.03.29
Annual Report 2009
2010.03.18
Allotted Share Options
2010.03.08
Shares purchased by employees and notification of trade
2010.02.19
Presentation 4th Quarter 2009
2010.02.19
Results 4th quarter and full year 2009
2010.02.16
Presentation of the annual report 2009
2010.01.13
Hexvix® receives reimbursement approval in Germany
2010.01.06
Inclusion completed in phase II study with Visonac™ for acne
2010.01.06
Financial calendar 2010
2009.12.31
Photocure received positive response from FDA on the New Drug Application (NDA) for Hexvix® for detection of bladder cancer
2009.12.18
FDA Advisory Committee voted favourably to Hexvix® application in USA
2009.11.26
Photocure granted patent in Europe and Russia for Visonac™ in the treatment of acne
2009.11.25
Extraordinary General Meeting
2009.11.23
Shares purchased by employees
2009.11.20
FDA has posted an Advisory Committee meeting with Photocure to discuss Hexvix® NDA
2009.11.03
Notice of extraordinary general meeting